These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
427 related items for PubMed ID: 32357246
1. Elevated STAT1 expression but not phosphorylation in lupus B cells correlates with disease activity and increased plasmablast susceptibility. Aue A, Szelinski F, Weißenberg SY, Wiedemann A, Rose T, Lino AC, Dörner T. Rheumatology (Oxford); 2020 Nov 01; 59(11):3435-3442. PubMed ID: 32357246 [Abstract] [Full Text] [Related]
2. The activity of JAK-STAT pathways in rheumatoid arthritis: constitutive activation of STAT3 correlates with interleukin 6 levels. Isomäki P, Junttila I, Vidqvist KL, Korpela M, Silvennoinen O. Rheumatology (Oxford); 2015 Jun 01; 54(6):1103-13. PubMed ID: 25406356 [Abstract] [Full Text] [Related]
3. Aberrant cell signalling in PBMCs upon IFN-α stimulation in primary Sjögren's syndrome patients associates with type I interferon signature. Davies R, Hammenfors D, Bergum B, Vogelsang P, Gavasso S, Brun JG, Jonsson R, Appel S. Eur J Immunol; 2018 Jul 01; 48(7):1217-1227. PubMed ID: 29604049 [Abstract] [Full Text] [Related]
4. STAT3 phosphorylation mediates the stimulatory effects of interferon alpha on B cell differentiation and activation in SLE. De Groof A, Ducreux J, Aleva F, Long AJ, Ferster A, van der Ven A, van de Veerdonk F, Houssiau FA, Lauwerys BR. Rheumatology (Oxford); 2020 Mar 01; 59(3):668-677. PubMed ID: 31504941 [Abstract] [Full Text] [Related]
5. Elevated unphosphorylated STAT1 and IRF9 in T and B cells of primary sjögren's syndrome: Novel biomarkers for disease activity and subsets. Ritter J, Szelinski F, Aue A, Stefanski AL, Rincon-Arevalo H, Chen Y, Nitschke E, Dang VD, Wiedemann A, Schrezenmeier E, Lino AC, Dörner T. J Autoimmun; 2024 Jul 01; 147():103243. PubMed ID: 38788537 [Abstract] [Full Text] [Related]
6. Autoantibody-Positive Healthy Individuals Display Unique Immune Profiles That May Regulate Autoimmunity. Slight-Webb S, Lu R, Ritterhouse LL, Munroe ME, Maecker HT, Fathman CG, Utz PJ, Merrill JT, Guthridge JM, James JA. Arthritis Rheumatol; 2016 Oct 01; 68(10):2492-502. PubMed ID: 27059145 [Abstract] [Full Text] [Related]
7. Activation of JAK-STAT1 signal transduction pathway in lesional skin and monocytes from patients with systemic lupus erythematosus. Li J, Zhao S, Yi M, Hu X, Li J, Xie H, Zhu W, Chen M. Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Feb 01; 36(2):109-15. PubMed ID: 21368418 [Abstract] [Full Text] [Related]
8. Multidimensional single cell based STAT phosphorylation profiling identifies a novel biosignature for evaluation of systemic lupus erythematosus activity. Huang X, Guo Y, Bao C, Shen N. PLoS One; 2011 Feb 01; 6(7):e21671. PubMed ID: 21799742 [Abstract] [Full Text] [Related]
9. TBK1: A key regulator and potential treatment target for interferon positive Sjögren's syndrome, systemic lupus erythematosus and systemic sclerosis. Bodewes ILA, Huijser E, van Helden-Meeuwsen CG, Tas L, Huizinga R, Dalm VASH, van Hagen PM, Groot N, Kamphuis S, van Daele PLA, Versnel MA. J Autoimmun; 2018 Jul 01; 91():97-102. PubMed ID: 29673738 [Abstract] [Full Text] [Related]
10. JAK Inhibitors Suppress Innate Epigenetic Reprogramming: a Promise for Patients with Sjögren's Syndrome. Charras A, Arvaniti P, Le Dantec C, Arleevskaya MI, Zachou K, Dalekos GN, Bordon A, Renaudineau Y. Clin Rev Allergy Immunol; 2020 Apr 01; 58(2):182-193. PubMed ID: 31165348 [Abstract] [Full Text] [Related]
11. Increased Levels of STAT1 Protein in Blood CD4 T Cells from Systemic Lupus Erythematosus Patients Are Associated with Perturbed Homeostasis of Activated CD45RA-FOXP3hi Regulatory Subset and Follow-Up Disease Severity. Goropevšek A, Gorenjak M, Gradišnik S, Dai K, Holc I, Hojs R, Krajnc I, Pahor A, Avčin T. J Interferon Cytokine Res; 2017 Jun 01; 37(6):254-268. PubMed ID: 28256939 [Abstract] [Full Text] [Related]
12. Artesunate inhibits type I interferon-induced production of macrophage migration inhibitory factor in patients with systemic lupus erythematosus. Feng X, Chen W, Xiao L, Gu F, Huang J, Tsao BP, Sun L. Lupus; 2017 Jan 01; 26(1):62-72. PubMed ID: 27230555 [Abstract] [Full Text] [Related]
13. Role of JAK-STAT signaling pathway in pathogenesis and treatment of primary Sjögren's syndrome. Li M, Li M, Qiao L, Wu C, Xu D, Zhao Y, Zeng X. Chin Med J (Engl); 2023 Oct 05; 136(19):2297-2306. PubMed ID: 37185152 [Abstract] [Full Text] [Related]
14. Acute alcohol intake induces SOCS1 and SOCS3 and inhibits cytokine-induced STAT1 and STAT3 signaling in human monocytes. Norkina O, Dolganiuc A, Catalano D, Kodys K, Mandrekar P, Syed A, Efros M, Szabo G. Alcohol Clin Exp Res; 2008 Sep 05; 32(9):1565-73. PubMed ID: 18616672 [Abstract] [Full Text] [Related]
15. JAK-STAT Activity in Peripheral Blood Cells and Kidney Tissue in IgA Nephropathy. Tao J, Mariani L, Eddy S, Maecker H, Kambham N, Mehta K, Hartman J, Wang W, Kretzler M, Lafayette RA. Clin J Am Soc Nephrol; 2020 Jul 01; 15(7):973-982. PubMed ID: 32354727 [Abstract] [Full Text] [Related]
16. Interferon α Enhances B Cell Activation Associated With FOXM1 Induction: Potential Novel Therapeutic Strategy for Targeting the Plasmablasts of Systemic Lupus Erythematosus. Akita K, Yasaka K, Shirai T, Ishii T, Harigae H, Fujii H. Front Immunol; 2020 Jul 01; 11():498703. PubMed ID: 33633721 [Abstract] [Full Text] [Related]
17. STAT-5 is activated constitutively in T cells, B cells and monocytes from patients with primary Sjögren's syndrome. Pertovaara M, Silvennoinen O, Isomäki P. Clin Exp Immunol; 2015 Jul 01; 181(1):29-38. PubMed ID: 25736842 [Abstract] [Full Text] [Related]
18. High Interferon Signature Leads to Increased STAT1/3/5 Phosphorylation in PBMCs From SLE Patients by Single Cell Mass Cytometry. Yiu G, Rasmussen TK, Tsai BL, Diep VK, Haddon DJ, Tsoi J, Miller GD, Comin-Anduix B, Deleuran B, Crooks GM, Utz PJ. Front Immunol; 2022 Jul 01; 13():833636. PubMed ID: 35185925 [Abstract] [Full Text] [Related]
19. Activation of the interferon-gamma signaling pathway in systemic lupus erythematosus peripheral blood mononuclear cells. Karonitsch T, Feierl E, Steiner CW, Dalwigk K, Korb A, Binder N, Rapp A, Steiner G, Scheinecker C, Smolen J, Aringer M. Arthritis Rheum; 2009 May 01; 60(5):1463-71. PubMed ID: 19404947 [Abstract] [Full Text] [Related]
20. Differential Responsiveness of Monocyte and Macrophage Subsets to Interferon. Han S, Zhuang H, Lee PY, Li M, Yang L, Nigrovic PA, Reeves WH. Arthritis Rheumatol; 2020 Jan 01; 72(1):100-113. PubMed ID: 31390156 [Abstract] [Full Text] [Related] Page: [Next] [New Search]